Prostate Cancer

Phase II trial finds patients may benefit from ipilimumab treatment despite low levels of gene mutations in the tumorCredit: The University of Texas MD Anderson Cancer Center HOUSTON -- Although metastatic castration-resistant prostate…

What The Study Did: Data for nearly 230,000 men were used in this study to examine variations in survival in prostate cancer by geographic areas in the United States. Authors: Quoc-Dien Trinh, M.D., of Harvard Medical School and Brigham…

Test also identifies where in the body the cancer has originatedCredit: Allen McCrodden, Associate Director, Creative Group of ProEd Communications Researchers have developed the first blood test that can accurately detect more than 50…

What The Study Did: This randomized clinical trial compared how effectively high-dose, targeted radiation therapy versus no treatment (observation) among 54 men prevented the progression over six months of recurrent hormone-sensitive…

Highly focused radiation can cause systemic immune response for men with limited spread of prostate cancerCredit: Phuoc Tran, M.D., Ph.D. Highly focused, intense doses of radiation called stereotactic ablative radiation (SABR) may slow…

Credit: Scott Leighow, Penn State Whether it is a drug-resistant strain of bacteria, or cancer cells that no longer react to the drugs intended to kill them, diverse mutations make cells resistant to chemicals, and "second generation"…

Vanderbilt researchers have identified haplotypes, ancestral fragments of DNA, that are associated with hereditary prostate cancer (HPC) in a first-of-its-kind genomic study made possible by the study of prostate cancer patients with…

Results from a randomised controlled trial involving 300 prostate cancer patients find that a molecular imaging technique is more accurate than conventional medical imaging and recommends the scans be introduced into routine clinical…

Researchers at the University of East Anglia have discovered why some prostate cancers are more aggressive, spread to different parts of the body, and ultimately cause death. It is hoped that the discovery, published today, could…

Associate Professor Anthony Leicht was part of an international group led by Professor John Saxton from Northumbria University and the University of East Anglia that studied how exercise might help prostate cancer sufferers who were about…

NCCN Quality and Outcomes Committee's endorsements of impactful and feasible quality and outcomes measures offer opportunities to advance the quality of cancer care in AmericaCredit: JNCCN PLYMOUTH MEETING, PA -- The National…

Pairing chemotherapy nanodrugs with a nutritional supplement can lessen devastating side-effects while reducing the amount of the expensive drugs needed to treat cancer according to a study from Carnegie Mellon University and Taiwan's…

Credit: Alina Kapitannikova Researchers of Sechenov University together with their colleagues from Australia used the microfluidics technology to develop a device able to isolate cancer cells from urine of patients with prostate cancer.…

Unnecessary prostate cancer biopsies could be reduced by 60 per cent thanks to new research from the University of East Anglia. Researchers have developed new methods to identify biomarkers for prostate cancer by combining information…

Scientists better predict recurrence of prostate cancer for black patients, according to new study; land $3.2 million in federal grants to explore racial bias in cancer diagnosis using Artificial Intelligence, computational imaging…

A method of testing for prostate cancer developed at the National Cancer Institute (NCI) leads to more accurate diagnosis and prediction of the course of the disease, according to a large study. This method, which combines systematic…

Use of this method may allow more patients to safely elect active surveillance rather than immediate treatment of low-risk cancersCredit: (c) University of Maryland Greenebaum Comprehensive Cancer Center BALTIMORE, MD - March 4,…

A new study links being overweight in middle age and later adulthood to a greater risk of advanced prostate cancer. Jeanine Genkinger, PhD, an epidemiologist at Columbia University Mailman School of Public Health, and colleagues published…

MAO inhibitor disrupts tumor growth pathway An antidepressant in use for decades, repurposed to fight prostate cancer, shows promise in helping patients whose disease has returned following surgery or radiation, a pilot study at USC shows.…

Also approves $16.4 million for new studies on maternal depression, HIV prevention, prostate cancer and care transitions WASHINGTON (March 3, 2020) -- The Patient-Centered Outcomes Research Institute (PCORI) Board of Governors at its March…